Company / Current Assets
Zomedica Corp. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$64.0M
FY2025
5-year range
$64.0M / $123.5M
FY2022-FY2025
Trend
-21.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 3 consecutive years, from $124M in FY2022 to $64M in FY2025.
Based on SEC 10-K filings.
$64M in FY2025 with a 3-year CAGR of -19.7%.
Declined from $100M to $64M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -19.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Zomedica Corp.'s current assets has declined for 3 consecutive years.
- 3-year CAGR of -19.7%, indicating a declining trend.
- In FY2025, current assets decreased 21.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.0M | -21.7% |
| FY2024 | $81.8M | -18.1% |
| FY2023 | $99.9M | -19.1% |
| FY2022 | $123.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026